ArticleInternational journal of women's health2025
Global Burden and Future Trends of Polycystic Ovary Syndrome: Insights from the GBD 2021 Study.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Prevalence and Clinical Features of Polyendocrine Metabolic Ovarian Syndrome in the Gulf Cooperation Council Countries: A Systematic Review and Meta-Analysis.Healthcare (Basel, Switzerland) · 2026Review
- Trends in PCOS Incidence, Prevalence, and DALYs Across Five BRICS Nations, 1990-2050: A Decomposition, Age-Period-Cohort, and Bayesian Forecasting Analysis Based on GBD 2021.International journal of women's health · 2026Article
- Global Burden of Polycystic Ovary Syndrome: A Systematic Analysis of Pre- and Post-Pandemic Trends from the 2021 Global Burden of Disease Study (1990-2021).International journal of women's health · 2026Article
- Pulmonary Function and Psychological Distress among Women with Polycystic Ovarian Syndrome: A Cross-sectional Study.Journal of human reproductive sciencesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age, defined by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. It is associated with infertility, metabolic abnormalities, and an increased cardiovascular risk. This study provides an updated and comprehensive analysis of PCOS burden from 1990 to 2021 using the latest Global Burden of Disease (GBD) dataset, focusing on trends, regional disparities, and future projections. Methods: Data on the prevalence, incidence, and disability-adjusted life years (DALYs) associated with PCOS were obtained from the GBD 2021. Temporal trends were evaluated using estimated annual percentage change (EAPC). Regional disparities were examined by stratifying data according to the socio-demographic index (SDI). Age-Period-Cohort (APC) modeling was employed to investigate disease dynamics across age groups and birth cohorts, while Bayesian Age-Period-Cohort (BAPC) models were utilized to project global burden trends through 2036. Results: In 2021, there were 65.8 million prevalent cases, 1.18 million incident cases, and 0.58 million DALYs due to PCOS globally. Middle SDI regions showed the highest growth rates in prevalence (EAPC 1.73%), incidence (EAPC 1.39%), and DALYs (EAPC 1.72%). Adolescents aged 15-19 demonstrated the highest incidence rates, while the peak prevalence shifted to women aged 30-34. High SDI regions had the highest age-standardized rates (ASRs), whereas Southeast Asia exhibited the most rapid growth. BAPC models forecast continued increases in PCOS burden, with prevalence projected to reach 77.87 million by 2036, though the age-standardized prevalence rate (ASPR) and age-standardized DALYs rate (ASDR) are expected to decline. Conclusion: PCOS represents an urgent global health challenge, with rising burdens, especially in middle-income regions. Targeted and equitable interventions are essential to improve early diagnosis, raise public awareness, and mitigate long-term health and socioeconomic consequences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.